Literature DB >> 3037993

Axilla skin biopsy: a reliable test for the diagnosis of Lafora's disease.

H L Busard, A A Gabreëls-Festen, W O Renier, F J Gabreëls, A M Stadhouders.   

Abstract

Skin biopsies from the axilla were examined in 7 patients with clinical signs and symptoms of Lafora's disease, in 9 relatives (7 parents and 2 siblings), and in 17 patients with chronic or progressive degenerative neurological disorders and chronic epilepsy, who served as controls. In the biopsies of all patients with Lafora's disease, typical periodic acid-Schiff (PAS)-positive inclusions were present in the myoepithelial cells of the secretory acini of the apocrine glands and/or in the cells of the eccrine duct. No abnormalities were found in the biopsies from relatives and controls. We conclude that axilla skin biopsy is an easy and reliable test for diagnosing Lafora's disease, and is preferable to liver biopsy, but has no value for carrier detection.

Entities:  

Mesh:

Year:  1987        PMID: 3037993     DOI: 10.1002/ana.410210613

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Lafora disease: epidemiology, pathophysiology and management.

Authors:  Thomas S Monaghan; Norman Delanty
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

2.  Identification of a recombination event narrowing the Lafora disease gene region.

Authors:  L O Maddox; M Descartes; J Collins; J Keating; S Rosenfeld; C Palmer; A J Carroll; R Kuzniecky
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

3.  Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates.

Authors:  Carolyn A Worby; Matthew S Gentry; Jack E Dixon
Journal:  J Biol Chem       Date:  2006-08-10       Impact factor: 5.157

4.  Polyglucosan bodies in intramuscular motor nerves.

Authors:  R A Bernsen; H L Busard; H J Ter Laak; F J Gabreëls; W O Renier; E M Joosten; A G Theeuwes
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Early-onset Lafora body disease.

Authors:  Julie Turnbull; Jean-Marie Girard; Hannes Lohi; Elayne M Chan; Peixiang Wang; Erica Tiberia; Salah Omer; Mushtaq Ahmed; Christopher Bennett; Aruna Chakrabarty; Atul Tyagi; Yan Liu; Nela Pencea; XiaoChu Zhao; Stephen W Scherer; Cameron A Ackerley; Berge A Minassian
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

6.  Early detection of skin and muscular involvement in Lafora disease.

Authors:  S Iannaccone; M Zucconi; A Quattrini; R Nemni; M Comola; L Taccagni; S Smirne
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

7.  Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).

Authors:  Carolyn A Worby; Matthew S Gentry; Jack E Dixon
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

8.  Diagnosis by axilla skin biopsy in an early case of Lafora's disease.

Authors:  G Rubio; C Garcia Guijo; J J Mallada; A Cabello; A Garcia Merino
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

9.  Lafora Disease Masquerading as Hepatic Dysfunction.

Authors:  Faisal Inayat; Waqas Ullah; Hanan T Lodhi; Zarak H Khan; Ghulam Ilyas; Nouman Safdar Ali; Hafez Mohammad A Abdullah
Journal:  Cureus       Date:  2018-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.